EXENDIN-4 ACETATE

Top drugs and pharmaceutical companies of 2019 by revenues

Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-

Teva to sell assets to reduce debt, lay-off 7,000 workers; Shkreli awaits sentence

This week in Phispers, we look at the growing troubles at Teva. The company plans to divest non-core